06872.HK
Tennor Therap-b
HKSE · Healthcare · Biotechnology · CN
HKD 168.00
−3.34%Aug 26, 2026, 09:28 UTC
Dano Pharmaceutical-B (06872.HK) reported interim results for the six months ended June 2026, with net loss narrowing to RMB 64.245 million from RMB 78.17 million in the same period last year, and no dividend declared.
Source: